|
| Press Releases |
|
 |
|
| Tuesday, August 1, 2023 |
|
|
iTolerance, Inc. and Northway Biotech Announce Partnership Agreement for Manufacturing of Streptavidin-FasL Fusion Protein for Innovative iTOL-100 Immunomodulatory Technology |
| iTOL-100 technology has broad applicability and can be applied to both allogenic and stem cell-derived organoids across a number of diseases. Manufacturing agreement supports advancement of iTolerance's development of iTOL-100 towards first in human clinical study for lead program, iTOL-102. more info >> |
|
|
iTolerance, Inc. and Northway Biotech Announce Partnership Agreement for Manufacturing of Streptavidin-FasL Fusion Protein for Innovative iTOL-100 Immunomodulatory Technology |
| iTOL-100 technology has broad applicability and can be applied to both allogenic and stem cell-derived organoids across a number of diseases. Manufacturing agreement supports advancement of iTolerance's development of iTOL-100 towards first in human clinical study for lead program, iTOL-102. more info >> |
|
| Thursday, May 25, 2023 |
|
|
Northway Biotech Set to Launch Advanced Microbial and Mammalian GMP Facilities in Massachusetts |
| Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), established in 2004, with an EMA and FDA-compliant, state-of-the-art cGMP manufacturing site in Vilnius, Lithuania, announced the completion of its expansion project for cGMP manufacturing facilities in Waltham, Massachusetts. This significant accomplishment further solidifies Northway Biotech's standing as an influential player in the global biopharmaceutical landscape. more info >> |
|
| Wednesday, May 17, 2023 |
|
|
tiakis Biotech AG and Northway Biotech: Successful Tech Transfer and Expansion of Manufacturing Capabilities for Tiprelestat |
| tiakis Biotech AG (tiakis), in collaboration with its CDMO partner Northway Biotech, is pleased to announce the successful completion of a technology transfer and ramp-up of manufacturing capabilities for Tiprelestat, a pioneering anti-inflammatory and tissue-protective drug being developed for the prevention of postoperative inflammatory complications following major surgery, treatment of COVID-19 and pulmonary arterial hypertension. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
富士通フィンランド、電気自動車向け充電ソリューションを提供するKempower様に包括的なITサービスを提供
Dec 5, 2023 11:00: JST
|
|
|
透云生物引领餐饮界新「潮流」 莱茵衣藻获逾百家知名餐饮品牌及米芝莲餐厅入馔
Dec 5, 2023 10:00 HKT/SGT
|
|
|
透雲生物引領餐飲界新「潮流」 萊茵衣藻獲逾百家知名餐飲品牌及米芝蓮餐廳入饌
Dec 5, 2023 09:59 HKT/SGT
|
|
|
Fujitsu Finland to provide comprehensive IT services to Kempower, provider of electric vehicle fast charging solutions
Dec 5, 2023 10:52 JST
|
|
|
Reach Announces Platform-Agnostic Global Tax Compliance Solution
Dec 5, 2023 08:00 HKT/SGT
|
|
|
BluWave-ai and Dubai Taxi Corporation Debut AI Optimization of EV Fleet
Dec 5, 2023 05:00 HKT/SGT
|
|
|
AJ Issenman Joins AELF FlightService as Director of Capital Markets
Dec 4, 2023 23:00 HKT/SGT
|
|
|
China Medical System: NDA for Additional RA Indication of Methotrexate Injection Accepted in China
Dec 4, 2023 22:52: JST
|
|
|
China Medical System: NDA for Additional RA Indication of Methotrexate Injection Accepted in China
Dec 4, 2023 21:49 HKT/SGT
|
|
|
SolidusMarkets Reports on 'Global Inflation Landscape and Impacts on Asset Classes'
Dec 4, 2023 21:26: JST
|
|
|
Wiz Acquires Raftt, Bolsters CNAPP Offering for Cloud and Kubernetes Developers
Dec 4, 2023 21:00 HKT/SGT
|
|
|
Atlas Lithium在2024年首次生產前已獲得充分資金支持
Dec 4, 2023 21:00 HKT/SGT
|
|
|
Atlas Lithium在2024年首次生产前已获得充分资金支持
Dec 4, 2023 21:00 HKT/SGT
|
|
|
Atlas Lithium Fully Funded to First Production in 2024
Dec 4, 2023 21:00 HKT/SGT
|
|
|
Q2 Metals Receives Proceeds of $2.0 Million from Shareholder Warrant Exercises
Dec 4, 2023 20:39 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
